Lexeo Therapeutics Inc (LXEO)

Dec 12, 2025

Janus Henderson Group PLC Expands Stake in Lexeo Therapeutics Inc - GuruFocus

Dec 12, 2025

Dec 12, 2025

Aug Wrap: Will Lexeo Therapeutics Inc stock benefit from AI adoptionStock Surge & Smart Allocation Stock Reports - moha.gov.vn

Dec 12, 2025

Dec 12, 2025

Lexeo Therapeutics (NASDAQ:LXEO) Receives “Buy” Rating from Chardan Capital - Defense World

Dec 12, 2025

Dec 11, 2025

Aug Action: What sentiment indicators say about Lexeo Therapeutics Inc stock - moha.gov.vn

Dec 11, 2025

Dec 11, 2025

Lexeo Therapeutics' (LXEO) Buy Rating Reaffirmed at Chardan Capital - MarketBeat

Dec 11, 2025

Dec 11, 2025

Lexeo Therapeutics (LXEO) Rating Maintained as 'Buy' by Chardan Capital | LXEO Stock News - GuruFocus

Dec 11, 2025

Dec 10, 2025

Oppenheimer reiterates Outperform rating on Lexeo Therapeutics stock By Investing.com - Investing.com Canada

Dec 10, 2025

Dec 10, 2025

Lexeo Therapeutics stock holds Overweight rating as Cantor sees PKP2-ACM potential - Investing.com Canada

Dec 10, 2025

Dec 10, 2025

Check Out Lexeo Therapeutics Inc (LXEO)’s Trade Data Rather Than the Analysts’ Views - setenews.com

Dec 10, 2025

Dec 10, 2025

Update Recap: Will Lexeo Therapeutics Inc stock benefit from AI adoptionJuly 2025 Fed Impact & Consistent Growth Equity Picks - moha.gov.vn

Dec 10, 2025

Dec 06, 2025

Portfolio Update: Why Lexeo Therapeutics Inc stock remains resilientJuly 2025 Review & Real-Time Buy Signal Notifications - moha.gov.vn

Dec 06, 2025

Dec 05, 2025

How resilient is Lexeo Therapeutics Inc. stock in market downturnsTreasury Yields & Fast Entry High Yield Stock Tips - Newser

Dec 05, 2025

Dec 04, 2025

Lexeo Therapeutics to Host Virtual Key Opinion Leader Event at the 22nd Global Cardiovascular Clinical Trialists (CVCT) Forum - marketscreener.com

Dec 04, 2025

Dec 04, 2025

Lexeo Therapeutics to Host Virtual Key Opinion Leader Event - GlobeNewswire

Dec 04, 2025

Dec 04, 2025

Why Lexeo Therapeutics Inc. stock remains resilientWeekly Stock Summary & Accurate Buy Signal Alerts - Newser

Dec 04, 2025

Dec 03, 2025

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Dec 03, 2025

Dec 02, 2025

Lexeo Therapeutics (NASDAQ:LXEO) Trading Down 7.8%What's Next? - MarketBeat

Dec 02, 2025

Dec 02, 2025

A look into Lexeo Therapeutics Inc (LXEO)’s deeper side - setenews.com

Dec 02, 2025

Dec 02, 2025

Lexeo Therapeutics (NASDAQ:LXEO) Now Covered by Analysts at Cantor Fitzgerald - MarketBeat

Dec 02, 2025

Dec 02, 2025

Lexeo Therapeutics stock undervalued, Cantor Fitzgerald reiterates $19 target By Investing.com - Investing.com Canada

Dec 02, 2025

Nov 28, 2025

Will Lexeo Therapeutics Inc. stock deliver shareholder valueExit Point & Consistent Income Trade Ideas - moha.gov.vn

Nov 28, 2025

Nov 26, 2025

Why Lexeo Therapeutics Inc. stock is a must watch in 2025July 2025 Patterns & Expert Approved Momentum Ideas - BỘ NỘI VỤ

Nov 26, 2025

Nov 25, 2025

Paradigm Biocapital Advisors LP Acquires Significant Stake in Le - GuruFocus

Nov 25, 2025

Nov 25, 2025

LXEO Stock Price and Chart — NASDAQ:LXEO - TradingView

Nov 25, 2025

Nov 24, 2025

Research Analysts Set Expectations for LXEO FY2025 Earnings - Defense World

Nov 24, 2025

Nov 22, 2025

Savant Capital LLC Invests $119,000 in Lexeo Therapeutics, Inc. $LXEO - MarketBeat

Nov 22, 2025

Nov 21, 2025

Insider Selling: Lexeo Therapeutics (NASDAQ:LXEO) CEO Sells 1,127 Shares of Stock - MarketBeat

Nov 21, 2025

Nov 21, 2025

Lexeo Therapeutics (NASDAQ:LXEO) Coverage Initiated at Cantor Fitzgerald - MarketBeat

Nov 21, 2025

Nov 21, 2025

Adler, Lexeo Therapeutics CMO, sells $5.7k in LXEO stock By Investing.com - Investing.com Australia

Nov 21, 2025

Nov 20, 2025

Lexeo Therapeutics CEO Makes Significant Stock Sale! - TipRanks

Nov 20, 2025

Nov 20, 2025

Balyasny Asset Management L.P. Increases Stake in Lexeo Therapeu - GuruFocus

Nov 20, 2025

Nov 20, 2025

[Form 4] Lexeo Therapeutics, Inc. Insider Trading Activity - Stock Titan

Nov 20, 2025

Nov 20, 2025

Adler, Lexeo Therapeutics CMO, sells $5.7k in LXEO stock - Investing.com

Nov 20, 2025

Nov 20, 2025

Lexeo Therapeutics CEO Sells Shares to Cover Tax Obligations - TradingView

Nov 20, 2025

Nov 20, 2025

CEO Townsend Surrenders 1,127 Of Lexeo Therapeutics Inc [LXEO] - TradingView

Nov 20, 2025

Nov 20, 2025

Cantor Fitzgerald Initiates Coverage on Lexeo Therapeutics With Overweight Rating, $19 Price Target - MarketScreener

Nov 20, 2025

Nov 20, 2025

Equities Analysts Set Expectations for LXEO FY2025 Earnings - MarketBeat

Nov 20, 2025

Nov 20, 2025

HC Wainwright Has Optimistic Outlook of LXEO FY2025 Earnings - Defense World

Nov 20, 2025

Nov 19, 2025

Lexeo Therapeutics Stock Rallies On Discussions With FDA To Expedite Friedreich’s Ataxia Drug Approval Process - MSN

Nov 19, 2025

Nov 19, 2025

Real time pattern detection on Lexeo Therapeutics Inc. stockMarket Activity Recap & Precise Entry and Exit Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Using Ichimoku Cloud for Lexeo Therapeutics Inc. technicalsWeekly Market Summary & Real-Time Volume Triggers - newser.com

Nov 19, 2025

Nov 19, 2025

Will Lexeo Therapeutics Inc. price bounce be sustainableGold Moves & Daily Entry Point Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Using data models to predict Lexeo Therapeutics Inc. stock movementQuarterly Trade Review & Reliable Entry Point Alerts - newser.com

Nov 19, 2025

Nov 18, 2025

Officer Tai Files To Sell 386 Of Lexeo Therapeutics Inc [LXEO] - TradingView

Nov 18, 2025

Nov 18, 2025

Institutional Investors Are Lexeo Therapeutics, Inc.'s (NASDAQ:LXEO) Biggest Bettors and Were Rewarded After Last Week's US$70m Market Cap Gain - 富途牛牛

Nov 18, 2025

Nov 18, 2025

Lexeo Therapeutics Insiders Benefitted From Selling Stock At US$7.01 - simplywall.st

Nov 18, 2025

Nov 17, 2025

Optimistic Buy Rating for Lexeo Therapeutics Driven by High-Dose Potential and Superior Safety Profile - TipRanks

Nov 17, 2025

Nov 16, 2025

V2Y Corporation Ltd Expands into Renewable Energy and Commodities - The Globe and Mail

Nov 16, 2025

Nov 16, 2025

Can Lexeo Therapeutics Inc. stock withstand economic slowdownWeekly Trend Summary & Stock Portfolio Risk Management - newser.com

Nov 16, 2025